| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 155, Issue 10 4882-4889, Copyright © 1995 by American Association of Immunologists
ARTICLES |
P Gasque, P Chan, M Fontaine, A Ischenko, M Lamacz, O Gotze and BP Morgan
Department of Medical Biochemistry, UWCM, Cardiff, United Kingdom.
The C fragment C5a exerts its important physiologic and pathologic effects through interaction with a specific C5a receptor (C5aR) which is highly expressed on polymorphonuclear leukocytes and some other leukocytes. The presence of this receptor on epithelia and endothelia has recently been documented, raising the possibility that these other cells might also respond to locally generated C5a. C has been implicated in several brain disorders, notably demyelination and neurodegeneration, and cells within brain can synthesize a complete C system. It is thus of interest to examine the mechanisms by which C damages or activates brain cells. To this end we have examined the expression on human fetal astrocytes and astrocyte-derived cell lines of receptors for C fragments. We here report that human astrocytes and cell lines express a receptor for C5a (48 to 72 x 10(3) copies/cell), which is indistinguishable at the protein or mRNA level from that in leukocytes. The astrocyte C5aR was recognized by five different specific Abs, which revealed by Western blotting a protein of 40 to 45 kDa in primary human astrocytes and astrocyte cell lines. Expression was confirmed by RT-PCR using multiple primers. Neither inflammatory cytokines nor PMA caused up-regulation of the receptor on astrocytes. The receptor was functional in that addition of C5a (1 nM to 100 nM) or, at high doses (100 nM), C5adesArg, triggered a calcium transient in astrocytes. We propose that C5aR expression on astrocytes plays an important role in control of inflammation in brain and may be a central component of C-mediated brain injury.
This article has been cited by other articles:
|
|
 |
|
  I. U. Schraufstatter, R. G. DiScipio, M. Zhao, and S. K. Khaldoyanidi C3a and C5a Are Chemotactic Factors for Human Mesenchymal Stem Cells, Which Cause Prolonged ERK1/2 Phosphorylation J. Immunol., March 15, 2009; 182(6): 3827 - 3836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Oda, K. Tokita, Y. Ota, Y. Li, K. Taniguchi, N. Nishino, K. Takagi, T. Yamamoto, and H. Nishiura Agonistic and Antagonistic Effects of C5a-Chimera Bearing S19 Ribosomal Protein Tail Portion on the C5a Receptor of Monocytes and Neutrophils, Respectively J. Biochem., September 1, 2008; 144(3): 371 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. B. Martin and B. K. Martin Characterization of the Murine C3a Receptor Enhancer-Promoter: Expression Control by an Activator Protein 1 Sequence and an Ets-Like Site J. Immunol., September 1, 2005; 175(5): 3123 - 3132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Boshra, T. Wang, L. Hove-Madsen, J. Hansen, J. Li, A. Matlapudi, C. J. Secombes, L. Tort, and J. O. Sunyer Characterization of a C3a Receptor in Rainbow Trout and Xenopus: The First Identification of C3a Receptors in Nonmammalian Species J. Immunol., August 15, 2005; 175(4): 2427 - 2437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Allen-Gipson, A. A. Floreani, A. J. Heires, S. D. Sanderson, R. G. MacDonald, and T. A. Wyatt Cigarette Smoke Extract Increases C5a Receptor Expression in Human Bronchial Epithelial Cells J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 476 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Baufreton, P. Allain, A. Chevailler, F. Etcharry-Bouyx, J. J. Corbeau, D. Legall, and J. L. de Brux Brain Injury and Neuropsychological Outcome After Coronary Artery Surgery Are Affected by Complement Activation Ann. Thorac. Surg., May 1, 2005; 79(5): 1597 - 1605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. van Beek, M. van Meurs, B. A. 't Hart, H. P. M. Brok, J. W. Neal, A. Chatagner, C. L. Harris, N. Omidvar, B. P. Morgan, J. D. Laman, et al. Decay-Accelerating Factor (CD55) Is Expressed by Neurons in Response to Chronic but Not Acute Autoimmune Central Nervous System Inflammation Associated with Complement Activation J. Immunol., February 15, 2005; 174(4): 2353 - 2365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Benard, B. J. Gonzalez, M.-T. Schouft, A. Falluel-Morel, D. Vaudry, P. Chan, H. Vaudry, and M. Fontaine Characterization of C3a and C5a Receptors in Rat Cerebellar Granule Neurons during Maturation: NEUROPROTECTIVE EFFECT OF C5a AGAINST APOPTOTIC CELL DEATH J. Biol. Chem., October 15, 2004; 279(42): 43487 - 43496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. H. Lo, H. Cheung, and Y. H. Wong Constitutively Active G{alpha}16 Stimulates STAT3 via a c-Src/JAK- and ERK-dependent Mechanism J. Biol. Chem., December 26, 2003; 278(52): 52154 - 52165. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. MONSINJON, P. GASQUE, P. CHAN, A. ISCHENKO, J. J. BRADY, and M. FONTAINE Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells FASEB J, June 1, 2003; 17(9): 1003 - 1014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Farkas, M. Takahashi, A. Fukuda, N. Yamamoto, H. Akatsu, L. Baranyi, H. Tateyama, T. Yamamoto, N. Okada, and H. Okada Complement C5a Receptor-Mediated Signaling May Be Involved in Neurodegeneration in Alzheimer's Disease J. Immunol., June 1, 2003; 170(11): 5764 - 5771. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. J. Laudes, J. C. Chu, M. Huber-Lang, R.-F. Guo, N. C. Riedemann, J. V. Sarma, F. Mahdi, H. S. Murphy, C. Speyer, K. T. Lu, et al. Expression and Function of C5a Receptor in Mouse Microvascular Endothelial Cells J. Immunol., November 15, 2002; 169(10): 5962 - 5970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. U. Schraufstatter, K. Trieu, L. Sikora, P. Sriramarao, and R. DiScipio Complement C3a and C5a Induce Different Signal Transduction Cascades in Endothelial Cells J. Immunol., August 15, 2002; 169(4): 2102 - 2110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. O'Barr, J. Caguioa, D. Gruol, G. Perkins, J. A. Ember, T. Hugli, and N. R. Cooper Neuronal Expression of a Functional Receptor for the C5a Complement Activation Fragment J. Immunol., March 15, 2001; 166(6): 4154 - 4162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Drouin, J. Kildsgaard, J. Haviland, J. Zabner, H. P. Jia, P. B. McCray Jr., B. F. Tack, and R. A. Wetsel Expression of the Complement Anaphylatoxin C3a and C5a Receptors on Bronchial Epithelial and Smooth Muscle Cells in Models of Sepsis and Asthma J. Immunol., February 1, 2001; 166(3): 2025 - 2032. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Singhrao, J. W. Neal, N. K. Rushmere, B. P. Morgan, and P. Gasque Spontaneous Classical Pathway Activation and Deficiency of Membrane Regulators Render Human Neurons Susceptible to Complement Lysis Am. J. Pathol., September 1, 2000; 157(3): 905 - 918. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L. Schieferdecker, G. Schlaf, M. Koleva, O. Gotze, and K. Jungermann Induction of Functional Anaphylatoxin C5a Receptors on Hepatocytes by In Vivo Treatment of Rats with IL-6 J. Immunol., May 15, 2000; 164(10): 5453 - 5458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Whitney, P. I. Andrews, and J. O. McNamara Immunoglobulin G and complement immunoreactivity in the cerebral cortex of patients with Rasmussen's encephalitis Neurology, September 1, 1999; 53(4): 699 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Wyatt, A. J. Heires, S. D. Sanderson, and A. A. Floreani Protein Kinase C Activation Is Required for Cigarette Smoke-Enhanced C5a-Mediated Release of Interleukin-8 in Human Bronchial Epithelial Cells Am. J. Respir. Cell Mol. Biol., August 1, 1999; 21(2): 283 - 288. [Abstract] [Full Text]
|
|
|
|
|
|
A. Fayyazi, R. Sandau, L. Q. Duong, O. Gotze, H. J. Radzun, S. Schweyer, A. Soruri, and J. Zwirner C5a Receptor and Interleukin-6 Are Expressed in Tissue Macrophages and Stimulated Keratinocytes but not in Pulmonary and Intestinal Epithelial Cells Am. J. Pathol., February 1, 1999; 154(2): 495 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J DEL ZOPPO, R. VON KUMMER, and G. F HAMANN Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke J. Neurol. Neurosurg. Psychiatry, July 1, 1998; 65(1): 1 - 9. [Full Text]
|
|
|
|
|
|
W. A. Wilmer, P. T. Kaumaya, J. A. Ember, and F. G. Cosio Receptors for the Anaphylatoxin C5a (CD88) on Human Mesangial Cells J. Immunol., June 1, 1998; 160(11): 5646 - 5652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Floreani, A. J. Heires, L. A. Welniak, A. Miller-Lindholm, L. Clark-Pierce, S. I. Rennard, E. L. Morgan, and S. D. Sanderson Expression of Receptors for C5a Anaphylatoxin (CD88) on Human Bronchial Epithelial Cells: Enhancement of C5a-Mediated Release of IL-8 upon Exposure to Cigarette Smoke J. Immunol., May 15, 1998; 160(10): 5073 - 5081. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Gasque, S. K. Singhrao, J. W. Neal, P. Wang, S. Sayah, M. Fontaine, and B. P. Morgan The Receptor for Complement Anaphylatoxin C3a Is Expressed by Myeloid Cells and Nonmyeloid Cells in Inflamed Human Central Nervous System: Analysis in Multiple Sclerosis and Bacterial Meningitis J. Immunol., April 1, 1998; 160(7): 3543 - 3554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I Farkas, L Baranyi, M Takahashi, A Fukuda, Z. Liposits, T Yamamoto, and H Okada A neuronal C5a receptor and an associated apoptotic signal transduction pathway J. Physiol., March 15, 1998; 507(3): 679 - 687. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Gasque, J. Jones, S. K. Singhrao, and B. Morgan Identification of an Astrocyte Cell Population from Human Brain that Expresses Perforin, a Cytotoxic Protein Implicated in Immune Defense J. Exp. Med., February 16, 1998; 187(4): 451 - 460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. VERKHRATSKY, R. K. ORKAND, and H. KETTENMANN Glial Calcium: Homeostasis and Signaling Function Physiol Rev, January 1, 1998; 78(1): 99 - 141. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
